GeneTether Overview

  • Founded
  • 2018
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $396K
Latest Deal Amount
  • Investors
  • 1

GeneTether General Information


Developer of gene editing technologies intended for human therapeutic applications. The company's technologies focus on developing improved gene editing technologies using CRISPR/Cas, TALEN, and Zinc-Finger, enabling users in improving gene editing efficiencies while reducing unintended unwanted DNA damage and mutation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 1477 Via Manzanas
  • San Lorenzo, CA 94580
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneTether Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 10-Feb-2021 $396K 00000 Completed Startup
1. Seed Round Completed Startup
To view GeneTether’s complete valuation and funding history, request access »

GeneTether Executive Team (2)

Name Title Board Seat Contact Info
Geoffrey Sargent Ph.D Founder, Chief Executive Officer & Chairman
David Tousley Chief Financial Officer
To view GeneTether’s complete executive team members history, request access »

GeneTether Board Members (5)

Name Representing Role Since
Albert Hansen KESA Partners Board Member 000 0000
Andre Figueiredo GeneTether Board Member 000 0000
Daren Graham JD GeneTether Board Member 000 0000
Geoffrey Sargent Ph.D GeneTether Founder, Chief Executive Officer & Chairman 000 0000
William Garner MD Self Board Member 000 0000
To view GeneTether’s complete board members history, request access »

GeneTether Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KESA Partners Merchant Banking Firm Minority 000 0000 000000 0
To view GeneTether’s complete investors history, request access »